Efficacy and safety of intravenous golimumab plus methotrexate in patients with rheumatoid arthritis aged < 65 years and those ≥ 65 years of age

OBJECTIVE: To evaluate the safety and efficacy of intravenous golimumab + methotrexate (MTX) in patients with active rheumatoid arthritis (RA) aged < 65 years and those ≥ 65 years who were enrolled in the GO-FURTHER study. METHODS: In the phase III, double-blind, randomized, placebo-controlled GO...

Descripción completa

Detalles Bibliográficos
Autores principales: Tesser, John, Kafka, Shelly, DeHoratius, Raphael J., Xu, Stephen, Hsia, Elizabeth C., Turkiewicz, Anthony
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6701065/
https://www.ncbi.nlm.nih.gov/pubmed/31429794
http://dx.doi.org/10.1186/s13075-019-1968-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6701065/
https://www.ncbi.nlm.nih.gov/pubmed/31429794
http://dx.doi.org/10.1186/s13075-019-1968-x

Ejemplares similares